Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

biopsy

“Frankenstein the Tumor” is No More

HOW MANY OF YOU HEARD ABOUT THE TUMOR NAMED “FRANKENSTEIN”? This is a story which made national news in mid-January and again in early February. The story line is simple. A nine-year old boy in Richmond, Virginia was diagnosed in May 2003 with embryonal rhabdomyosarcoma. A grapefruit-sized tumor…

Read More



Aligning Pathologist Productivity With Compensation Can Be Challenging

“Growing interest in ways to link a pathologist’s productivity to his/her compensation makes this a widely-discussed topic within many pathology group practices.” –Dennis Padget CEO SUMMARY: Part Three continues THE DARK REPORT’S series on meas…

Read More



Making a Difference in Tangible Ways

HOW OFTEN DOES SOMETHING you learn from THE DARK REPORT make a positive difference in your laboratory? We hear lots of examples from our clients and regular readers and I’d like to share two of them with you today. The first example comes from our special, exclusive, and expanded coverage about an…

Read More



How Local Path Groups Can Keep Patient Access

CEO SUMMARY: For pathology groups operating their own histology and cytology labs, a growing problem is access to patients covered by exclusive managed care contracts. In the Northeast, several persistent pathology group practices are using some effective business strategies to fight this…

Read More



“Actionable Intelligence” In Real Time

BEFORE YOU READ THIS ISSUE, I would like to make three observations. Each will help you get maximum value from the information contained herein about the trend of in-house anatomic pathology (AP) laboratories in specialist physician groups. First, THE DARK REPORT’S coverage of this trend is unmatc…

Read More



Part II: Path Condo Labs As A Threat to Pathology

SPECIALIST PHYSICIAN GROUPS are taking active steps to capture anatomic pathology (AP) revenues that result from specimens generated by their groups’ patients. Yet the anatomic pathology profession is only now awakening to this threat. To educate and alert pathologists and their group practice adm…

Read More



Peeking Into Finances Of Pathology Lab Condos

CEO SUMMARY: In the possession of THE DARK REPORT is a copy of revenue and expense projections shown by a pathology condo laboratory complex promoter to prospective urology groups. They project that even smaller urology groups can realize worthwhile income if they invest in a pathology co…

Read More



AP Test Over-Utilization Will Be One Achilles’ Heel

CEO SUMMARY: Over-utilization is likely to be a prime concern when federal healthcare enforcers eventually investigate in-house anatomic pathology laboratories owned by specialist physicians. Some in-house pathology lab condo promoters are basing financial performance on 100% utilization …

Read More



Changing Economics Motivate Urologists & GIs

CEO SUMMARY: Over the past 18 months, more specialist groups have created their own anatomic pathology laboratories than were created in the past five years. It’s a gold rush to tap and capture profits generated by the anatomic pathology services provided to their patient populations. T…

Read More



National AP Firms Target Gastroenterology Groups

CEO SUMMARY: It’s a trend as yet invisible to the radar screens of most pathology groups. A new crop of specialty AP companies is targeting gastroenterology. In the past 36 months, several have posted phenomenal growth in both specimen volume and revenue. The heightened competition for …

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;